From operator to API: how the future of micronisation means no more compromise
Despite industry investment in large molecule drugs, demand for small molecule active pharmaceutical ingredients (API) manufacturing remains high. Driven by…
Frewitt
Latest in
Frewitt
Partner content
Meet the Swiss company creating a new gold standard in micronisation and user safety
Nestled at the foot of the picturesque Alps in central Switzerland for more than 75 years, Frewitt S.A. provides powder…
Partner content
Turnkey pharma projects: Why working with a process-driven solutions provider is the key to success
The demand for turnkey solutions in the pharmaceutical processing industry is increasing yearly. Pharmaceutical and fine chemical companies have less…
Partner content
How one company is embracing collaboration to advance pharmaceutical technology
It was the famous American industrialist Henry Ford who once said: “Coming together is the beginning. Keeping together is progress.…
Partner content
Down to the nanometre: Submicron particle size reduction and the NanoWitt bead mill
Bigger does not always mean better in the pharmaceutical world. A prime example is found in powder manufacturing, where reduced…
Partner content
The Smallest of Particles Offer the Biggest Challenges
With our experience in powder milling and fragmentation, at Frewitt, we have established ourselves as leaders in this field over…
Partner content
Frewitt’s Technical Center and process consultancy
Milling, grinding, crushing, micronising, nanomilling, sieving, de-agglomerating are all terms synonymous with particle size reduction, but most significantly, they are…